Miach Orthopaedics commenced limited U.S. launch of the BEAR® Implant in select cities for the treatment of anterior cruciate ligament (ACL) tears. The BEAR Implant was also awarded a Popular Science Best of What’s New Award for representing a significant step forward in health.
The BEAR Implant is the first medical technology to clinically demonstrate that it enables healing of a patient’s torn ACL. It offers an alternative to the current standard of care – reconstruction that replaces the ACL with a graft.
The proprietary, bio-engineered BEAR Implant restores ACL quality and size similar to the non-injured ACL, results in faster recovery of muscle strength and has better patient satisfaction with being ready to return to sports. The BEAR Implant also does not require a graft, eliminating the need for a second wound site to heal and worries about donor graft quality or risk of disease.
“We’ve been overwhelmed by the interest from patients who’ve torn their ACLs and are actively seeking an alternative to the current standard of care,” said Martha Shadan, president and CEO, Miach Orthopaedics. “We’re honored the BEAR Implant was selected by Popular Science as one of the best new health products of the year, and we are excited to make this innovative treatment available for patients.”
Miach Orthopaedics commenced limited U.S. launch of the BEAR® Implant in select cities for the treatment of anterior cruciate ligament (ACL) tears. The BEAR Implant was also awarded a Popular Science Best of What’s New Award for representing a significant step forward in health.
The BEAR Implant is the first medical technology to clinically...
Miach Orthopaedics commenced limited U.S. launch of the BEAR® Implant in select cities for the treatment of anterior cruciate ligament (ACL) tears. The BEAR Implant was also awarded a Popular Science Best of What’s New Award for representing a significant step forward in health.
The BEAR Implant is the first medical technology to clinically demonstrate that it enables healing of a patient’s torn ACL. It offers an alternative to the current standard of care – reconstruction that replaces the ACL with a graft.
The proprietary, bio-engineered BEAR Implant restores ACL quality and size similar to the non-injured ACL, results in faster recovery of muscle strength and has better patient satisfaction with being ready to return to sports. The BEAR Implant also does not require a graft, eliminating the need for a second wound site to heal and worries about donor graft quality or risk of disease.
“We’ve been overwhelmed by the interest from patients who’ve torn their ACLs and are actively seeking an alternative to the current standard of care,” said Martha Shadan, president and CEO, Miach Orthopaedics. “We’re honored the BEAR Implant was selected by Popular Science as one of the best new health products of the year, and we are excited to make this innovative treatment available for patients.”
Copy to clipboard 
